Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Charles River Laboratories International, Inc. Common Stock
(NY:
CRL
)
356.32
-0.95 (-0.27%)
Delayed Quote
Updated: 11:30 AM EDT, Oct 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Charles River Laboratories International, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
2 healthcare stocks to keep an eye on and 1 that underwhelm
October 23, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...
Via
StockStory
3 mid-cap stocks walking a fine line
October 22, 2026
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...
Via
StockStory
S&P 500 Top Movers: Oct. 21, 2026 US Session
↗
October 21, 2026
Via
Chartmill
Topics
Stocks
S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Losers
↗
October 21, 2026
Via
Chartmill
Topics
Stocks
S&P 500 Top Movers: EFX and HAS Lead Today's Gainers, GM and DVA Fall
↗
October 20, 2026
Via
Chartmill
Topics
Stocks
S&P 500 Top Movers: Gainers and Losers From Today's US Session
↗
October 20, 2026
Via
Chartmill
Topics
Stocks
Drug Development Inputs & Services Stocks Q2 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers
October 15, 2026
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Charles River Laboratories (NY...
Via
StockStory
1 S&P 500 Stock to Target This Week and 2 We Question
October 12, 2026
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...
Via
StockStory
Topics
Fraud
Stocks
Stay informed with the top movers within the S&P500 index on Thursday.
↗
October 08, 2026
Via
Chartmill
Uncover the latest developments among S&P500 stocks in today's session.
↗
October 05, 2026
Via
Chartmill
Which S&P500 stocks are moving on Monday?
↗
October 05, 2026
Via
Chartmill
Charles River Targets 5%-7% Growth, $300M Savings in 2030 Plan
↗
September 25, 2026
Charles River Laboratories International (NYSE:CRL) outlined a strategy to accelerate growth, expand margins and modernize its operations during its 2026 Investor Day, setting financial targets through...
Via
MarketBeat
Topics
Artificial Intelligence
Discover which S&P500 stocks are making waves on Thursday.
↗
September 24, 2026
Via
Chartmill
Why Charles River Laboratories (CRL) Stock Is Up Today
September 24, 2026
What Happened? Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 5.7% in the afternoon session after the company outlined long-term...
Via
StockStory
Topics
Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session.
↗
September 24, 2026
Via
Chartmill
3 Unpopular Stocks Walking a Fine Line
September 23, 2026
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...
Via
StockStory
These S&P500 stocks are moving in today's session
↗
September 22, 2026
Via
Chartmill
Why Charles River Laboratories (CRL) Stock Is Trading Up Today
September 17, 2026
What Happened? Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 3.6% in the afternoon session after the company announced the laun...
Via
StockStory
3 Reasons to Sell CRL and 1 Stock to Buy Instead
September 16, 2026
What a fantastic six months it’s been for Charles River Laboratories. Shares of the company have skyrocketed 79.5%, hitting $272.74. This was partly thanks t...
Via
StockStory
Wall Street Is Now Backing the Clarity Act. Here's the Most Likely Scenario for What Happens Next With Crypto.
↗
August 27, 2026
Even if there's no clarity on the Clarity Act, Coinbase and Circle could still power higher over the next 12 months.
Via
The Motley Fool
Topics
Government
Here's How Much $100 Invested In Charles River 15 Years Ago Would Be Worth Today
↗
August 25, 2026
Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 2.75% on an annualized basis producing an average annual return of 15.76%. Currently, Charles River has a market...
Via
Benzinga
3 Inflated Stocks We Approach with Caution
August 25, 2026
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a...
Via
StockStory
If You Invested $100 In Charles River Stock 15 Years Ago, You Would Have This Much Today
↗
August 14, 2026
Charles River (NYSE:CRL) has outperformed the market over the past 15 years by 2.07% on an annualized basis producing an average annual return of 15.79%. Currently, Charles River has a market...
Via
Benzinga
1 Mid-Cap Stock with Exciting Potential and 2 Facing Challenges
August 14, 2026
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...
Via
StockStory
Charles River Laboratories (CRL) Q2 2026 Earnings Call Transcript
↗
August 12, 2026
Organic revenue returned to growth as biopharmaceutical demand strengthened.
Via
The Motley Fool
Topics
Earnings
5 Insightful Analyst Questions From Charles River Laboratories’s Q2 Earnings Call
August 12, 2026
Charles River Laboratories’ second quarter results were shaped by recovering biopharmaceutical demand and the impact of portfolio streamlining. Management hi...
Via
StockStory
Topics
Artificial Intelligence
Earnings
Economy
Charles River Laboratories International Q2 Earnings Call Highlights
↗
August 06, 2026
Charles River Laboratories International (NYSE:CRL) reported second-quarter results that exceeded its prior outlook, citing improved demand in its Discovery and Safety Assessment, or DSA, business and...
Via
MarketBeat
Topics
Earnings
CRL Q2 Deep Dive: Strategic Portfolio Moves and Biopharma Demand Fuel Margin Expansion
August 06, 2026
Lab services company Charles River Laboratories (NYSE:CRL) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, but sales fell by 2.7% year on ...
Via
StockStory
Wednesday's session: top gainers and losers in the S&P500 index
↗
August 05, 2026
Via
Chartmill
Top S&P500 movers in Wednesday's session
↗
August 05, 2026
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
